These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2836982)

  • 1. [Involvement of cyclic GMP in the physiological and pathological functions of the atrial natriuretic factor].
    Hamet P; Tremblay J
    Union Med Can; 1988 Feb; 117(1):85-9. PubMed ID: 2836982
    [No Abstract]   [Full Text] [Related]  

  • 2. Physiology. The expanding physiological roles of atrial natriuretic factor.
    Needleman P
    Nature; 1986 May 15-21; 321(6067):199-200. PubMed ID: 3012350
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recent advances in the study of atrial natriuretic factor].
    Zhao G; He RR
    Sheng Li Ke Xue Jin Zhan; 1986 Jul; 17(3):244-9. PubMed ID: 3026042
    [No Abstract]   [Full Text] [Related]  

  • 4. Cellular mechanisms of action of atrial natriuretic factor.
    Gerzer R; Heim JM; Schütte B; Weil J
    Klin Wochenschr; 1987; 65 Suppl 8():109-14. PubMed ID: 2885440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of action of atrial natriuretic factor: clinical consequences.
    Gerzer R; Weil J; Strom T; Müller T
    Klin Wochenschr; 1986; 64 Suppl 6():21-6. PubMed ID: 2879064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac natriuretic peptides: gaining further insights into structure-function relationships.
    de Bold AJ
    J Am Coll Cardiol; 2009 Sep; 54(11):1033-4. PubMed ID: 19729121
    [No Abstract]   [Full Text] [Related]  

  • 7. Atrial natriuretic factor receptor heterogeneity and stimulation of particulate guanylate cyclase and cyclic GMP accumulation.
    Leitman DC; Murad F
    Endocrinol Metab Clin North Am; 1987 Mar; 16(1):79-105. PubMed ID: 2892671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Guanylate cyclases: physiological processes mediated by cyclic GMP].
    Rivero-Vilches F; de Frutos S; Rodríguez-Puyol M; Rodríguez-Puyol D; Saura M
    Nefrologia; 2001; 21(3):233-9. PubMed ID: 11471303
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationships between circulating ANP, cyclic GMP and sodium excretion in normal human subjects.
    Sagnella GA; Markandu ND; Buckley MG; Singer DR; MacGregor GA
    J Hum Hypertens; 1993 Apr; 7(2):181-2. PubMed ID: 8389873
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of guanylate cyclase by atrial natriuretic factor and the role of cyclic GMP in vasodilation.
    Murad F; Leitman DC; Bennett BM; Molina C; Waldman SA
    Am J Med Sci; 1987 Sep; 294(3):139-43. PubMed ID: 2889359
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclic GMP/protein kinase G phosphorylation of Smad3 blocks transforming growth factor-beta-induced nuclear Smad translocation: a key antifibrogenic mechanism of atrial natriuretic peptide.
    Buxton IL; Duan D
    Circ Res; 2008 Feb; 102(2):151-3. PubMed ID: 18239144
    [No Abstract]   [Full Text] [Related]  

  • 12. Physiologically regulated atrial natriuretic peptide receptors in renal glomeruli.
    Ballermann BJ; Brenner BM
    Trans Assoc Am Physicians; 1985; 98():92-100. PubMed ID: 3022448
    [No Abstract]   [Full Text] [Related]  

  • 13. Is cyclic GMP a clinically useful marker for ANF action?
    Heim JM; Gottmann K; Weil J; Haufe MC; Gerzer R
    Z Kardiol; 1988; 77 Suppl 2():41-6. PubMed ID: 2841815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The atrial natriuretic factor: its physiology and biochemistry.
    Genest J; Cantin M
    Rev Physiol Biochem Pharmacol; 1988; 110():1-145. PubMed ID: 2835808
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclic GMP as mediator and biological marker of atrial natriuretic factor.
    Hamet P; Tremblay J; Pang SC; Skuherska R; Schiffrin EL; Garcia R; Cantin M; Genest J; Palmour R; Ervin FR
    J Hypertens Suppl; 1986 Jun; 4(2):S49-56. PubMed ID: 2873213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial natriuretic factor as a multifunctional peptide: regulation of vasomotor tone and cellular growth.
    Appel RG
    Exp Nephrol; 1994; 2(2):147. PubMed ID: 8082015
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase.
    Rodriguez-Pascual F; Miras-Portugal MT; Torres M
    Mol Pharmacol; 1996 Jun; 49(6):1058-70. PubMed ID: 8649344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial natriuretic factor significantly contributes to the mineralocorticoid escape phenomenon. Evidence for a guanylate cyclase-mediated pathway.
    Yokota N; Bruneau BG; Kuroski de Bold ML; de Bold AJ
    J Clin Invest; 1994 Nov; 94(5):1938-46. PubMed ID: 7962539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling.
    Zhang Q; Moalem J; Tse J; Scholz PM; Weiss HR
    Eur J Pharmacol; 2005 Mar; 510(3):209-15. PubMed ID: 15763244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation by low sodium intake of glomerular response to cicletanine and atrial natriuretic factor.
    Kalinowski L; Szczepanska-Konkel M; Jankowski M; Angielski S
    Br J Pharmacol; 1997 Jun; 121(4):635-42. PubMed ID: 9208128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.